Note: Ingredients listed on restricted chemical lists
EC/CAS
202-849-4/100-41-4
Name of the chemical
Ethylbenzene
Concentration
=1-<2,5
EC/CAS
202-966-0/101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=0,1-<1 >=5% >=5% >=5% >=0,1%
General Information
Version
9.1
Revision date
2021-11-29
Product name
ΑΡΜΟΚΟΛΛΑ ΠΟΛΥΟΥΡΕΘΑΝΗΣ ΑΣΠΡΗ 310ML
1.2.1 Relevant identified uses
Adhesives Professional use product
Emergency telephone
0030 210 6290800, 0030 210 6290890, 210 7793777, (0030) 210 7793777, (0030) 210 6290800
Icons in SDS
Company Information
company name
Würth Hellas SA
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Hazardous Ingredients
4,4'-Diphenylmethane diisocyanate 4,4'-Methylenediphenyl diisocyanate, oligomers
Additional information
EUH212 Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. "As from 24 August 2023 adequate training is required before industrial or pro- fessional use."
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome).
